Expion Health’s Accelerating Growth Earns Second Consecutive Inc. 5000 Recognition

North Bethesda, MD — August 14, 2026 — Expion Health®, a leader in next-generation prescription economics, announced it has been ranked on the 2026 Inc. 5000, the annual list of the fastest-growing private companies in America.

This marks Expion’s second consecutive appearance on the Inc. 5000 and a significant rise from its ranking. In one year, Expion improved its ranking by nearly 77% and moved to approximately the top 21% of this year’s list.

The recognition comes as the pharmacy benefits market continues to change rapidly. Rising costs, evolving access dynamics, regulatory shifts, rebate complexity and changing member needs are challenging traditional approaches to pharmacy strategy. Expion’s growth reflects increasing demand from health plans, pharmacy benefit managers and self-funded employers for modular solutions that provide greater flexibility, visibility and control without requiring a full-scale replacement of existing infrastructure.

“Being named to the Inc. 5000 for the second consecutive year is an exciting milestone, but what matters most is what that continued growth represents,” said Karin Humphrey, CEO of Expion Health. “It reflects the growing demand for a different approach to pharmacy strategy—and the value our teams are delivering for organizations navigating an increasingly complex market. Our clients need greater flexibility, visibility and control to act as the market changes, and that is exactly what we are building. This recognition reinforces our commitment to Build Pharmacy Forward and gives us even more momentum for what comes next.”

Expion’s growth reflects increasing demand for a more flexible approach to pharmacy strategy. As cost, access, regulation and market dynamics evolve, health plans, PBMs and self-funded employers need the ability to adapt without replacing the infrastructure and capabilities that already work.

Expion’s modular model enables organizations to add and connect the capabilities they need across rebate management, formulary strategy, analytics and execution. Powered by ExpionIQ®, the company’s award-winning insights and performance platform, Expion helps clients turn complex pharmacy data into greater visibility, more informed decisions and coordinated action.

At the same time, Expion is helping expand how pharmacy value is defined and measured. Its focus on total-value prescription performance brings financial accountability, regulatory confidence, clinical decision-making and outcomes together—giving organizations greater clarity and control over their prescription strategy as the market changes.

“This year’s Inc. 5000 recognizes a new class of companies redefining what growth looks like,” said Mike Hofman, editor-in-chief of Inc. “Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still. Their growth reflects more than strong financial performance—it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement.”

The Inc. 5000 recognizes the nation’s fastest-growing private companies and has included companies such as Microsoft, Meta, Chobani, Oracle and Patagonia among its past honorees. The 2026 list recognizes companies across industries that are expanding their impact, creating jobs and contributing to growth in the U.S. economy. The complete 2026 Inc. 5000 list is available at Inc.com.